The Los Angeles Post
U.S. World Business Lifestyle
Today: February 18, 2025
Today: February 18, 2025
Patrick  Wingrove

Patrick Wingrove

Staff Writer

Latest From Patrick Wingrove

Business|Economy|Health|Science|US

Moderna norovirus vaccine trial on hold by US FDA over neurological side effect

Moderna said on Friday that the U.S.

Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Economy|Environment|Health|Political|Science

Trump cuts could clash with Kennedy's long to-do list

Robert F.

Trump cuts could clash with Kennedy's long to-do list
Business|Economy|Finance|Health|Stock Markets|US

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about

Lilly reassures investors that weight-loss drug demand is strong, shares rise
Business|Economy|Health|Political|US

Trump faces pressure from US industry over China tariff on medicines

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports,

Trump faces pressure from US industry over China tariff on medicines
Business|Economy|Finance|Health|US

Lilly needs a plan to spur weight-loss drug sales, investors say

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after

Lilly needs a plan to spur weight-loss drug sales, investors say
Business|Finance|Health|US

J&J beats quarterly sales and profit estimates on cancer drug sales

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter revenues and profit above Wall

J&J beats quarterly sales and profit estimates on cancer drug sales
Health|Political|US|World

Trump orders US exit from World Health Organization

The United States will leave the World Health Organization, President Donald Trump said on Monday, saying the

Trump orders US exit from World Health Organization
Business|Finance|Health

J&J profit edges past Street view after deals delay Stelara competition

Johnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug

J&J profit edges past Street view after deals delay Stelara competition
Business|Finance|Health|US

Drugmakers sign on to negotiate Medicare prices under protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S.

Drugmakers sign on to negotiate Medicare prices under protest
Health|News|US

Over 7 million Americans have gotten updated COVID vaccines

More than 7 million Americans had rolled up their sleeves for the updated COVID-19 vaccines as of Wednesday, according to the U.S.

Over 7 million Americans have gotten updated COVID vaccines
Business|Health

J&J to restructure orthopedic business after medical device sales miss

Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter medical devices

J&J to restructure orthopedic business after medical device sales miss
Business|Finance|Health|US

Moderna revenue tops expectations, expects to return to sales growth in 2025

Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 vaccines this year, but that it would return

Moderna revenue tops expectations, expects to return to sales growth in 2025
Business|Finance|Health|US

Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies

Novo Nordisk on Thursday said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active

Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
Business|Finance|Health|US

Eli Lilly's obesity drug now available in U.S. pharmacies

Eli Lilly said on Tuesday its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for

Eli Lilly's obesity drug now available in U.S. pharmacies
Business|Health|News|US

Exclusive-US FDA finds control lapses at Moderna manufacturing plant

U.S. drug regulators in September found quality control lapses at Moderna’s main factory including with equipment used to manufacture drug substance for its COVID-19

Exclusive-US FDA finds control lapses at Moderna manufacturing plant
Business|Finance|Health

Lilly rides wave of weight-loss drug demand, working to expand capacity

Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for Zepbound, its recently approved weight-loss drug, and said

Lilly rides wave of weight-loss drug demand, working to expand capacity
Business|Health|US

US FDA finds control lapses at Catalent plant being sold to Novo

U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a "pest

US FDA finds control lapses at Catalent plant being sold to Novo
Business|Finance|Health

Moderna reports surprise profit, sets out road map for RSV vaccine

Moderna on Thursday reported a surprise fourth-quarter profit helped by cost cutting and some deferred payments, and the vaccine maker set out a

Moderna reports surprise profit, sets out road map for RSV vaccine
Health|Technology|US

Healthcare providers hit by frozen payments in ransomware outage

Healthcare providers across the United States are struggling to get paid following the week-long ransomware outage at a

Healthcare providers hit by frozen payments in ransomware outage
Business|Health|Technology

Factbox-Who and what is the hack of UnitedHealth's tech unit affecting?

The Feb. 21 ransomware hack at UnitedHealth Group's Change Healthcare technology unit, which processes insurance claims and payments for the industry, has disrupted

Factbox-Who and what is the hack of UnitedHealth's tech unit affecting?
Business|Health|Technology

Lilly partners with Amazon to deliver Zepbound and other drugs

Eli Lilly said on Wednesday it has brought on Amazon.com's pharmacy unit to deliver drug prescriptions sent to its direct-to-consumer service, LillyDirect.

Lilly partners with Amazon to deliver Zepbound and other drugs
Business|Finance|Health

Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says

Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company's revenue growth per year from deals to supply makers of drugs for weight loss and diabetes

Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
Health|News|Science

WHO warns of falsified cough syrup ingredients seized in Pakistan

The World Health Organization issued an alert on Monday warning drugmakers of five contaminated batches of propylene glycol, an ingredient used in medicinal syrups,

WHO warns of falsified cough syrup ingredients seized in Pakistan
Business|Finance|Stock Markets|US

Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda

Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer drug Keytruda, sending the company's shares

Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Business|Finance|Health|US

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S.

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

Follow